BIMATOPROST, BIMATOPROST NHPL, BIMATOPROST NEOHEALTH, LUMIPROST, LUMATOGAN, BIMATOLUGAN, BIMATIGAN, LUMITOPROST (Neo Health (Australia) Pty Ltd)
Product name
BIMATOPROST, BIMATOPROST NHPL, BIMATOPROST NEOHEALTH, LUMIPROST, LUMATOGAN, BIMATOLUGAN, BIMATIGAN, LUMITOPROST
Sponsor
Date registered
Evaluation commenced
Decision date
Approval time
162 working days (255)
Active ingredients
Bimatoprost
Registration type
New generic medicine
Indication
BIMATOPROST, BIMATOPROST NHPL, BIMATOPROST NEOHEALTH, LUMIPROST, LUMATOGAN, BIMATOLUGAN, BIMATIGAN, LUMITOPROST (eye drops) is indicated for the reduction of elevated intraocular pressure, or open angle glaucoma, as first line therapy or monotherapy or as adjunctive therapy to topical beta-blockers.